Hdm2-p53 inhibitor (Merck & Co)

N/A

Report date: 2025/01/26 19:14:48
NME

Base Information

Drug NameHdm2-p53 inhibitor (Merck & Co)
Drug Alias NameHdm2-p53 inhibitor (Schering-Plough)Hdm2 antagonist (Merck)SCH-1450206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesSchering-Plough Corp
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A